Search - tctmd.com

Displaying 21 - 40 of 55

Sort: Relevancy | Date

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Daily News

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

L.A. McKeown

October 29, 2019

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

Caitlin E. Cox

April 12, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

Presentation

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

February 06, 2019

News Daily News

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Yael L. Maxwell

September 17, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

Presentation EuroPCR 2018

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

Presenter: Lars Sondergaard

May 25, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

Shelley Wood

April 02, 2018

News Conference News ACC 2018

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Shelley Wood

March 10, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Daily News

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

L.A. McKeown

February 07, 2018

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Conference News ACC 2017

Live From Washington: ACC 2017, Day One

Shelley Wood

March 17, 2017

Advertisement

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

Latest Observational Data Support TAVR Durability Through 7 Years

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Low Risk

TAVR Without Balloon Aortic Valvuloplasty: Increasingly Common, With Similar Outcomes

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

Longevity of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients with Severe Aortic Stenosis and Lower Surgical Risk

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

TCTMD’s Top 10 Most Popular Stories for March 2018

NOTION: 5-Year Outcomes for TAVR Match SAVR in Low-Risk Patients

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Meta-analysis Raises ‘Red Flag’ on TAVR in Low-Risk Patients

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Live From Washington: ACC 2017, Day One

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content